These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 7051464)

  • 1. Blood transfusion and kidney transplantation: effect of small doses of blood on kidney graft function and survival.
    Sirchia G; Mercuriali F; Pizzi C; Rosso di San Secondo VE; Borzini P; Aniasi A
    Transplant Proc; 1982 Jun; 14(2):263-71. PubMed ID: 7051464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney graft survival: role of blood transfusions and lymphocytotoxic antibodies.
    Fradet Y; Roy R; Lachance JG; Noël R
    Clin Nephrol; 1982 Aug; 18(2):69-73. PubMed ID: 6754190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of transfusions on renal allograft survival in the cyclosporine era: a single center report.
    Egidi MF; Scott DH; Corry RJ
    Clin Transplant; 1993 Jun; 7(3):240-4. PubMed ID: 10148843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of blood transfusions on first cadaveric graft and uremic patient survival.
    Solheim BG; Flatmark A; Halvorsen S; Jervell J; Pape J; Thorsby E
    Scand J Urol Nephrol Suppl; 1980; 54():55-9. PubMed ID: 7013044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood transfusions and kidney transplantation: selection or conditioning of recipients?].
    op den Winkel R; Brunner F; Harder F
    Helv Chir Acta; 1980 Jun; 47(1-2):227-30. PubMed ID: 7002876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the active thymus derived rosette forming cells in renal allograft survival: a preliminary report.
    Kerman RH; Ing TS; Hano JE; Geis WP
    Surgery; 1977 Nov; 82(5):607-12. PubMed ID: 335551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of renal allograft survival in DLA-tissue typed beagles after third-party leucocyte and erythrocyte transfusion.
    Obertop H; Bijnen AB; Schreve RH; Westbroek DL
    Proc Eur Dial Transplant Assoc; 1979; 16():366-71. PubMed ID: 398508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney transplantation in rhesus monkeys. Matching for D/DR antigens, pretransplant blood transfusions, and immunological monitoring before transplantation.
    Borleffs JC; Marquet RL; de By-Aghai Z; van Vreeswijk W; Neuhaus P; Balner H
    Transplantation; 1982 Mar; 33(3):285-90. PubMed ID: 6461114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft survival with high levels of cytotoxic antibodies.
    Feduska NJ; Amend WJ; Vincenti F; Perkins HA; Opelz G; Terasaki PI; Iwaki Y; Duca R; Dodge D; Salvatierra O
    Transplant Proc; 1981 Mar; 13(1 Pt 1):73-80. PubMed ID: 7022910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic selection of renal transplant donors and recipients: blood transfusions].
    Seignalet J; Mourad G; Mion C
    Nephrologie; 1984; 5(3):123-9. PubMed ID: 6387521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal allograft survival in patients transfused perioperatively only.
    Fassbinder W; Frei U; Scheuermann EH; Bechstein PB; Raab R; Dathe G; Jonas D; Knöner M; Hanke P; Schoeppe W
    Proc Eur Dial Transplant Assoc; 1983; 20():291-6. PubMed ID: 6361741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood transfusion and human renal transplantation.
    Grunnet N; Kristiansen J; Rohr N; Birkeland SA; Svendsen V
    Scand J Urol Nephrol Suppl; 1980; 54():60-2. PubMed ID: 7013046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cadaveric renal graft survival: the bearing of the number of blood transfusions and of dialysis treatment.
    Fehrman I; Fehrman J; Lundgren G; Möller E; Groth CG
    Scand J Urol Nephrol Suppl; 1980; 54():49-51. PubMed ID: 7013042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deliberate buffy-coat transfusions and the risk of antibody formation.
    Takahashi H; Iwaki Y; Terasaki PI; Okazaki H; Ishizaki M; Sekino H; Momma M; Takemoto S
    Transplant Proc; 1982 Jun; 14(2):349-54. PubMed ID: 7051477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of blood transfusions on renal allograft survival.
    Sengar DP; Rashid A; Jindal SL
    Transplant Proc; 1979 Mar; 11(1):179-81. PubMed ID: 377627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusion and kidney graft survival in Finland.
    Tiilikainen A; Kock B; Kuhlbäck B; Wallenius M
    Scand J Urol Nephrol Suppl; 1977; (42):70-2. PubMed ID: 356227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody response and allograft outcome with deliberate donor-specific blood transfusions.
    Mendez R; Iwaki Y; Mendez RG; Bogaard T; Self B; Konoeda Y; Terasaki PI
    Transplant Proc; 1982 Jun; 14(2):378-82. PubMed ID: 7051482
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
    Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
    Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Possible mechanism of the beneficial effect of pretransplant blood transfusions on renal allograft survival in man.
    Singal DP; Joseph S; Szewczuk MR
    Transplant Proc; 1982 Jun; 14(2):316-8. PubMed ID: 6214059
    [No Abstract]   [Full Text] [Related]  

  • 20. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.